Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Ancell
anti-CD133 (human), mAb (ANC9C5)
306
CHF
CHF 306.00
In stock
ANC-363-020100 µgCHF 306.00
Figure 1: Five x 10^5 human Y-79 retinoblastoma cells were washed incubated 45min on ice with 80µl of anti-human CD133 antibody (#ANC-363-020) at 5 µg/ml. Cells were washed twice and incubated with Goat-anti-Mouse/FITC, after which they were washed twice, fixed and analyzed by FACS. Cells stained positive with a mean shift of 0.9 log10 fluorescent units when compared to isotype control Mouse IgG1 antibody (#ANC-278-010).
Product Details | |
---|---|
Synonyms | Prominin-1; PROM1; AC133; Prominin-like Protein 1 |
Product Type | Monoclonal Antibody |
Properties | |
Clone | ANC9C5 |
Isotype | Mouse IgG1κ |
Source/Host | Purified from concentrated hybridoma tissue culture supernatant. |
Immunogen/Antigen | WERI-Rb-1 human retinoblastoma cells. |
Application |
Flow Cytometry |
Crossreactivity | Human |
Specificity |
Recognizes human CD133. |
Purity | ≥95% (SDS-PAGE) |
Purity Detail | Protein A purified. |
Concentration | 1mg/ml |
Formulation | Liquid, 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 0.5mg/ml Gentamicin sulfate |
Isotype Negative Control | |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Ancell Corporation. |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Handling Advice | Avoid freeze/thaw cycles. |
Use/Stability | Stable for at least 1 year after receipt when stored at +4°C. |
Documents | |
Application Note | Download PDF |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
Human CD133 is a 117kd pentaspan transmembrane glycoprotein expressed by a subset of hematopoetic and other types of stem cells found in blood and a variety of tissues. Increased expression of CD133 may be a predictor of decreased prognosis in patients with metastatic cancer. Antibody ANC9C5 recognizes epitope 1 of human CD133(AC133) present on full length CD133 transfectants, Y79 retinoblastoma and other cell types. Antibody ANC9C5 has been used to image cancer stem cells in a colon carcinoma xenograft.
Product References
- Basic studies on radioimmunotargeting of CD133-positive HCT116 cancer stem cells: Z.-H. Jin, et al.; Mol. Imaging 11, 445 (2012)